Inhibitory Effect of Herbal Remedy PERVIVO and Anti-Inflammatory Drug Sulindac on L-1 Sarcoma Tumor Growth and Tumor Angiogenesis in Balb/c Mice

Table 5

Statistical analysis of the results presented in Figure 5.

(a)  

One-way ANOVA
Source of variation	% of total variation	𝑃 value	𝑃 value summary	Significant?
Interaction	1.53	0.0101	*	Yes
Drug	4.25	<0.0001	***	Yes

(b)  

Bonferroni test	Mean difference	𝑡	𝑃 value	Summary
Control versus sulindac	−6.000	0.5758	𝑃 > 0.05	ns
Control versus PERVIVO	−16.00	1.535	𝑃 > 0.05	ns
Control versus sulindac + PERVIVO	−58.00	6.935	𝑃 < 0.001	***
Sulindac versus sulindac + PERVIVO	−52.00	4.990	𝑃 < 0.001	***
PERVIVO versus sulindac + PERVIVO	−42.00	4.030	𝑃 < 0.001	***
Control versus sulindac	−6.000	0.5758	𝑃 > 0.05	ns
Control versus PERVIVO	−16.00	1.535	𝑃 > 0.05	ns
Control versus sulindac + PERVIVO	−58.00	6.935	𝑃 < 0.001	***
Sulindac versus sulindac + PERVIVO	−52.00	4.990	𝑃 < 0.001	***
PERVIVO versus sulindac + PERVIVO	−42.00	4.030	𝑃 < 0.001	***

^∗𝑃<0.05, ***𝑃<0.001.